FDA approval of generic mifepristone revives false claims that the medication is unsafe
Reproductive healthOther posts discussed dwindling access to reproductive health care services....
Explore discourse about reproductive health and use our real-time dashboards below for the most up-to-date information in your area. Insights are updated by Monday of each week.
Jump to dashboardsMost recent
Other posts discussed dwindling access to reproductive health care services....
Plus, social media users spread false claims about mifepristone safety and expressed fear about how an FDA review could potentially limit access to it....
Social media users also debated the difference between birth control and abortion, discussed ectopic pregnancy risks, and promoted false claims about HPV vaccine safety....
Plus, commenters discussed pain management during gynecological procedures....
Other posts discussed an upcoming HHS report expected to link prenatal acetaminophen use to autism....
Meanwhile, commenters debated a lawsuit aiming to restrict access to abortion pills, resurfacing false claims that they are unsafe....
Plus, allegations that a Virginia public school social worker helped a minor student obtain an abortion stoked conversation about parental consent....
Plus, posts highlighted rising STI rates in Mississippi and inaccurate curriculum used in some states’ sex education....
Other posts highlighted challenges with breastfeeding and debated whether abortion bans delay miscarriage treatment....
Plus, social media users discussed laws impacting minors seeking abortions and debated a survey about support for legalizing abortion....
Dashboards
Click here to explore the latest data at the national and regional level.
Looking for support with your own infodemiology work, or want to partner to advance the field? Complete the form below or contact our team at info@infodemiology.com.